Semaglutide Leads to Greater Weight Loss in Women Than Men With HF, Improves HF Symptoms in Both Sexes
June 25, 2024
June 25, 2024
WASHINGTON, June 25 (TNSres) -- The American College of Cardiology issued the following news release on June 23, 2024:
* * *
An update in the STEP-HfpEF Program study gives key insights into sex differences and semaglutide
* * *
Key Findings:
* Weight Loss: Women lost 9.6% of their body weight on average with semaglutide, compared with 7.2% in men, marking a significant difference.
* Symptom Improvement: Both sexes saw . . .
* * *
An update in the STEP-HfpEF Program study gives key insights into sex differences and semaglutide
* * *
Key Findings:
* Weight Loss: Women lost 9.6% of their body weight on average with semaglutide, compared with 7.2% in men, marking a significant difference.
* Symptom Improvement: Both sexes saw . . .